Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Birth control pill increases risks of cervical and breast cancer

Scientists are now saying that women who take the birth control pill could be increasing their risk of cervical and breast cancer.

31 Jul 2005

Discovery could improve the early diagnosis of breast and ovarian cancers through a simple blood test

Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a simple blood test.

28 Jul 2005

Novel treatment for ovarian cancer

The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States.

15 Jul 2005

Tricirbine may help fight cancers

H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (USF), has discovered a new use for an old, previously discredited anti-cancer drug that could add another weapon in the arsenal against several cancers, including tumors of the breast, ovary, colon, skin and prostate.

27 Jun 2005

PET might be a promising tool for early prediction of response to chemotherapy for ovarian can

Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

A new study funded by the National Cancer Institute reports that social support and other behavioral factors are related to levels of a circulating protein, which at high levels is associated with a poor prognosis in advanced ovarian cancer.

13 Jun 2005

Possible new treatment for chemobrain using the drug dexmethyphenidate (d-MPH)

Patients who take medication for cancer often find themselves with a new problem when their treatment ends.

8 Jun 2005

Harmful chemicals may reprogram gene response to estrogen

New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.

1 Jun 2005

Having twins reduces the risk of many types of women's cancer

...and starting a family later in life increases risk of breast cancer and melanoma but reduces the risk of ovarian, cervix and uterine cancer according to an international study conducted by a team from The Queensland Institute of Medical Research (QIMR).

1 Jun 2005

Environment factors can interact with genetics to increase disease risk

31 May 2005

Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumors

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine’s Journal of Nuclear Medicine.

29 May 2005

Team IDs mechanism for multiplying adult stem cells

While research on human embryonic stem cells gets most of the press, scientists are also investigating the potential therapeutic uses of adult stem cells. Although less controversial, this research faces other difficulties. Adult stem cells are extremely difficult to isolate and multiply in the lab.

24 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

Moderate recreational and work-related physical activity may reduce the risk of ovarian cancer

While the benefits of physical activity in reducing colon and breast cancer are well established, results of studies on exercise and ovarian cancer have been inconclusive. Because ovarian cancer has such a poor prognosis, it is even more important to identify modifiable lifestyle factors that could prevent it.

16 May 2005

Broken bones may reduce risk of ovarian cancer

The pain and suffering of a broken bone may yield an unexpected benefit – a reduced risk of ovarian cancer.

10 May 2005

Many lives may be saved by new blood test for ovarian cancer

A new blood test which has the potential to save many lives has been developed to detect ovarian cancer, a disease known as the silent killer because it is so difficult to identify.

9 May 2005

Blocking the COX-1 enzyme might be the answer in ovarian cancer treatment

Researchers at Vanderbilt University Medical Center in a new report say that blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer.

2 May 2005

Blocking the COX-1 enzyme might prevent and treat the most common and fatal form of ovarian cancer

Blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer, researchers at Vanderbilt University Medical Center reported this week.

1 May 2005

Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa

Researchers at Fox Chase Cancer Center in Philadelphia have identified a subset of ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa. The research was presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif.

20 Apr 2005

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Birth control pill increases risks of cervical and breast cancer

Discovery could improve the early diagnosis of breast and ovarian cancers through a simple blood test

Novel treatment for ovarian cancer

Tricirbine may help fight cancers

PET might be a promising tool for early prediction of response to chemotherapy for ovarian can

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

Possible new treatment for chemobrain using the drug dexmethyphenidate (d-MPH)

Harmful chemicals may reprogram gene response to estrogen

Having twins reduces the risk of many types of women's cancer

Environment factors can interact with genetics to increase disease risk

Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumors

Team IDs mechanism for multiplying adult stem cells

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

Moderate recreational and work-related physical activity may reduce the risk of ovarian cancer

Broken bones may reduce risk of ovarian cancer

Many lives may be saved by new blood test for ovarian cancer

Blocking the COX-1 enzyme might be the answer in ovarian cancer treatment

Blocking the COX-1 enzyme might prevent and treat the most common and fatal form of ovarian cancer

Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in